Bank of America
SYRE icon

Bank of America’s Spyre Therapeutics SYRE Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$5.93M Sell
396,351
-30,724
-7% -$460K ﹤0.01% 3168
2025
Q1
$6.89M Buy
427,075
+419,933
+5,880% +$6.78M ﹤0.01% 2965
2024
Q4
$166K Sell
7,142
-250,655
-97% -$5.84M ﹤0.01% 5322
2024
Q3
$7.58M Buy
257,797
+66,628
+35% +$1.96M ﹤0.01% 2850
2024
Q2
$4.49M Buy
191,169
+154,837
+426% +$3.64M ﹤0.01% 3176
2024
Q1
$1.38M Buy
+36,332
New +$1.38M ﹤0.01% 3970
2023
Q2
Sell
-35,230
Closed -$10.2K 6921
2023
Q1
$10.2K Buy
35,230
+19,460
+123% +$5.64K ﹤0.01% 6090
2022
Q4
$7.08K Buy
15,770
+4,094
+35% +$1.84K ﹤0.01% 6177
2022
Q3
$6K Buy
11,676
+4,375
+60% +$2.25K ﹤0.01% 6484
2022
Q2
$4K Sell
7,301
-10,704
-59% -$5.86K ﹤0.01% 6821
2022
Q1
$41K Sell
18,005
-13,062
-42% -$29.7K ﹤0.01% 6458
2021
Q4
$147K Buy
31,067
+5,428
+21% +$25.7K ﹤0.01% 5855
2021
Q3
$204K Buy
25,639
+5,423
+27% +$43.1K ﹤0.01% 5460
2021
Q2
$141K Sell
20,216
-19,474
-49% -$136K ﹤0.01% 5535
2021
Q1
$314K Buy
39,690
+26,173
+194% +$207K ﹤0.01% 5082
2020
Q4
$106K Sell
13,517
-35,973
-73% -$282K ﹤0.01% 5221
2020
Q3
$351K Buy
49,490
+30,153
+156% +$214K ﹤0.01% 4383
2020
Q2
$179K Buy
19,337
+5,907
+44% +$54.7K ﹤0.01% 4778
2020
Q1
$63K Sell
13,430
-11,611
-46% -$54.5K ﹤0.01% 5177
2019
Q4
$191K Sell
25,041
-2,824
-10% -$21.5K ﹤0.01% 4884
2019
Q3
$214K Buy
27,865
+1,355
+5% +$10.4K ﹤0.01% 4848
2019
Q2
$182K Buy
26,510
+12,822
+94% +$88K ﹤0.01% 4946
2019
Q1
$111K Sell
13,688
-3,457
-20% -$28K ﹤0.01% 5082
2018
Q4
$128K Buy
17,145
+12,858
+300% +$96K ﹤0.01% 5052
2018
Q3
$41K Buy
4,287
+1,417
+49% +$13.6K ﹤0.01% 5550
2018
Q2
$31K Sell
2,870
-4,574
-61% -$49.4K ﹤0.01% 5614
2018
Q1
$74K Buy
7,444
+444
+6% +$4.41K ﹤0.01% 5155
2017
Q4
$38K Hold
7,000
﹤0.01% 5381
2017
Q3
$35K Buy
+7,000
New +$35K ﹤0.01% 5289
2016
Q4
Sell
-445
Closed -$3K 6404
2016
Q3
$3K Sell
445
-400
-47% -$2.7K ﹤0.01% 5952
2016
Q2
$4K Buy
+845
New +$4K ﹤0.01% 5920